David M. Burns
Research Subjects
David M. Burns has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Christy M. Anderson
UCSD School of Medicine – Family and Preventive Medicine, University of California-San Diego, Del Mar, CA, USA
4 shared publications- Donald R Shopland
National Cancer Institute, Rockville, Maryland, USA
2 shared publications Nigel Gray
Cancer Council of Victoria, Melbourne, Australia
2 shared publicationsA M Hartman
1 shared publicationA Opperhuizen
11National Institute of Public Health and the Environment (RIVM), The Netherlands
1 shared publicationC Anderson
UCSD School of Medicine, San Diego, California, USA
1 shared publication
Latest Publications
- 18 July 2014
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 27 (8) , 1330-1335
Changing Rates of Adenocarcinoma of the Lung
Over the past several decades, adenocarcinoma of the lung has been increasing as a fraction of all lung cancer. Examination of the available evidence led the 2014 Report of the Surgeon General to conclude that the increases in the rates of adenocarcinoma among smokers in the U.S. were a result of changes in cigarette design and composition over the past 6 decades. While a causal link to design and composition changes as a whole is clear, the changes that have been implemented over the past several decades are not uniformly applied across all cigarette brands in the current market, raising questions about differences in risks among users of different cigarette brands. Recognition of the increased risks resulting from design and composition changes offers a corollary opportunity to reduce current disease risks by identifying and regulating the specific compositional and design changes that produced the increase in risk.
- 18 July 2014
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 27 (8) , 1330-1335
Changing Rates of Adenocarcinoma of the Lung
Over the past several decades, adenocarcinoma of the lung has been increasing as a fraction of all lung cancer. Examination of the available evidence led the 2014 Report of the Surgeon General to conclude that the increases in the rates of adenocarcinoma among smokers in the U.S. were a result of changes in cigarette design and composition over the past 6 decades. While a causal link to design and composition changes as a whole is clear, the changes that have been implemented over the past several decades are not uniformly applied across all cigarette brands in the current market, raising questions about differences in risks among users of different cigarette brands. Recognition of the increased risks resulting from design and composition changes offers a corollary opportunity to reduce current disease risks by identifying and regulating the specific compositional and design changes that produced the increase in risk.
- Open Access
- 7 August 2012
- Published by Wiley in Risk Analysis
- Vol. 32 (s1) , S14-S24
Chapter 2: Birth‐Cohort‐Specific Estimates of Smoking Behaviors for the U.S. Population
We present methods for estimating five‐year birth‐cohort‐specific trends in smoking behavior for individuals born between 1910 and 1984. We combine cross‐sectional survey data on smoking behavior from the National Health Interview Surveys (NHIS) conducted between 1965 and 2001 into a single data set. The cumulative incidence of smoking by year of age and calendar year is constructed for each birth cohort from this data set and the effect of differential mortality on ever smoking prevalence is adjusted by modeling the ever smoking prevalence of each cohort for each survey year and back extrapolating that effect to age 30. Cumulative incidence is then scaled to match the ever smoking prevalence at age 30. Survival analyses generate the cumulative cessation among ever smokers across year of age and calendar year and are used to estimate current smoking prevalence. Data from Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health is used to divide those initiating smoking into quintiles of number of cigarettes smoked per day (CPD) and the mean CPD for each quintile in each calendar year is estimated from the NHIS data. For five‐year birth cohorts of white, african‐american, Hispanic and all race/ethnicity groupings of males and females born between 1910 and 1984, estimates are provided for prevalence of current and ever smoking, incidence of cessation, incidence of initiation, and the distribution of smoking duration and CPD for each calendar year and each single year of age through the year 1999. We believe that we are the first to provide birth‐cohort‐specific estimates of smoking behaviors for the U.S. population that include distributions of duration of smoking and number of cigarettes per day. These additional elements substantively enhance the utility of these estimates for estimating lung cancer risks.
- 7 August 2012
- Published by Wiley in Risk Analysis
- Vol. 32 (s1) , S14-S24
Open AccessChapter 2: Birth‐Cohort‐Specific Estimates of Smoking Behaviors for the U.S. Population
We present methods for estimating five‐year birth‐cohort‐specific trends in smoking behavior for individuals born between 1910 and 1984. We combine cross‐sectional survey data on smoking behavior from the National Health Interview Surveys (NHIS) conducted between 1965 and 2001 into a single data set. The cumulative incidence of smoking by year of age and calendar year is constructed for each birth cohort from this data set and the effect of differential mortality on ever smoking prevalence is adjusted by modeling the ever smoking prevalence of each cohort for each survey year and back extrapolating that effect to age 30. Cumulative incidence is then scaled to match the ever smoking prevalence at age 30. Survival analyses generate the cumulative cessation among ever smokers across year of age and calendar year and are used to estimate current smoking prevalence. Data from Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health is used to divide those initiating smoking into quintiles of number of cigarettes smoked per day (CPD) and the mean CPD for each quintile in each calendar year is estimated from the NHIS data. For five‐year birth cohorts of white, african‐american, Hispanic and all race/ethnicity groupings of males and females born between 1910 and 1984, estimates are provided for prevalence of current and ever smoking, incidence of cessation, incidence of initiation, and the distribution of smoking duration and CPD for each calendar year and each single year of age through the year 1999. We believe that we are the first to provide birth‐cohort‐specific estimates of smoking behaviors for the U.S. population that include distributions of duration of smoking and number of cigarettes per day. These additional elements substantively enhance the utility of these estimates for estimating lung cancer risks.
- Open Access
- 10 April 2012
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 175 (9) , 970-971
Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition: By Robert N. Proctor
Editor’s Note: The review of Robert Proctor’s Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition merits comment. In writing the book, Robert Proctor has drawn on the tobacco industry’s formerly secret internal documents to describe how the industry caused the epidemic of tobacco use and the resulting massive burden of premature mortality and morbidity. Even before its publication, the industry tried to obtain (by subpoena) a draft of the book; more recently, it attempted to thwart the introduction of this book as evidence in litigation. David Burns, the book’s reviewer, has been involved in tobacco control since the 1970s, when he began to edit and write reports of the Surgeon General on smoking and health.
- 10 April 2012
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 175 (9) , 970-971
Open AccessGolden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition: By Robert N. Proctor
Editor’s Note: The review of Robert Proctor’s Golden Holocaust: Origins of the Cigarette Catastrophe and the Case for Abolition merits comment. In writing the book, Robert Proctor has drawn on the tobacco industry’s formerly secret internal documents to describe how the industry caused the epidemic of tobacco use and the resulting massive burden of premature mortality and morbidity. Even before its publication, the industry tried to obtain (by subpoena) a draft of the book; more recently, it attempted to thwart the introduction of this book as evidence in litigation. David Burns, the book’s reviewer, has been involved in tobacco control since the 1970s, when he began to edit and write reports of the Surgeon General on smoking and health.
- Open Access
- 25 December 2010
- Published by Springer Nature in Cancer Causes & Control
- Vol. 22 (3) , 389-397
Has the lung cancer risk from smoking increased over the last fifty years?
Background We examine whether the lung cancer risk due to smoking has increased over time. Methods Lung cancer risk equations based on prospective mortality data collected from 1960 to 1972 were applied to 5-year birth-cohort-specific estimates of smoking behaviors among white males to estimate lung cancer mortality rates for U.S. white males from 1960 to 2000. These estimated rates were compared to U.S. white male mortality rates for the same birth cohorts. Results Observed birth-cohort-specific U.S. lung cancer mortality rates are substantially higher than those expected from changes in smoking behaviors, and the proportional difference increases with advancing calendar year. This trend persisted even when the duration term was increased in the risk equation. However, adjusting for changes in cigarette design over time by adding a term for the duration of smoking after 1972 resulted in the predicted rates closely approximating the observed U.S. mortality rates. Conclusion Lung cancer risk estimates observed during the 1960s under predict current lung cancer mortality rates in U.S. white males. Adjustment for the duration of smoking after 1972 results in estimates that reasonably approximate the observed U.S. lung cancer mortality, suggesting that lung cancer risks from smoking are increasing in the United States coincident with changes in cigarette design.
- 25 December 2010
- Published by Springer Nature in Cancer Causes & Control
- Vol. 22 (3) , 389-397
Open AccessHas the lung cancer risk from smoking increased over the last fifty years?
Background We examine whether the lung cancer risk due to smoking has increased over time. Methods Lung cancer risk equations based on prospective mortality data collected from 1960 to 1972 were applied to 5-year birth-cohort-specific estimates of smoking behaviors among white males to estimate lung cancer mortality rates for U.S. white males from 1960 to 2000. These estimated rates were compared to U.S. white male mortality rates for the same birth cohorts. Results Observed birth-cohort-specific U.S. lung cancer mortality rates are substantially higher than those expected from changes in smoking behaviors, and the proportional difference increases with advancing calendar year. This trend persisted even when the duration term was increased in the risk equation. However, adjusting for changes in cigarette design over time by adding a term for the duration of smoking after 1972 resulted in the predicted rates closely approximating the observed U.S. mortality rates. Conclusion Lung cancer risk estimates observed during the 1960s under predict current lung cancer mortality rates in U.S. white males. Adjustment for the duration of smoking after 1972 results in estimates that reasonably approximate the observed U.S. lung cancer mortality, suggesting that lung cancer risks from smoking are increasing in the United States coincident with changes in cigarette design.
- Open Access
- 22 October 2010
- Published by Springer Nature in Cancer Causes & Control
- Vol. 22 (1) , 13-22
Do changes in cigarette design influence the rise in adenocarcinoma of the lung?
Background Incidence rates for adenocarcinoma of the lung are increasing and are higher in the United States than in many other developed countries. We examine whether these trends may be associated with changes in cigarette design. Methods Lung cancer risk equations based on observations during 1960–1972 from the American Cancer Society Cancer Prevention Study I are applied to 5-year birth cohort–specific estimates of changes in smoking behaviors to predict birth cohort–specific rates of squamous cell carcinoma and adenocarcinoma of the lung among US White men for the period 1973–2000. These expected rates are compared to observed rates for the same birth cohorts of White men in the US Surveillance, Epidemiology and End Results (SEER) data. Results Changes in smoking behaviors over the past several decades adequately explain the changes in squamous cell carcinoma rates observed in the SEER data. However, predicted rates for adenocarcinoma do not match the observed SEER data without inclusion of a term increasing the risk for adenocarcinoma with the duration of smoking after 1965. Conclusion The risk of developing squamous cell carcinoma from smoking appears to have remained stable in the United States over the past several decades; however, the risk of adenocarcinoma has increased substantially in a pattern temporally associated with changes in cigarette design.
- 22 October 2010
- Published by Springer Nature in Cancer Causes & Control
- Vol. 22 (1) , 13-22
Open AccessDo changes in cigarette design influence the rise in adenocarcinoma of the lung?
Background Incidence rates for adenocarcinoma of the lung are increasing and are higher in the United States than in many other developed countries. We examine whether these trends may be associated with changes in cigarette design. Methods Lung cancer risk equations based on observations during 1960–1972 from the American Cancer Society Cancer Prevention Study I are applied to 5-year birth cohort–specific estimates of changes in smoking behaviors to predict birth cohort–specific rates of squamous cell carcinoma and adenocarcinoma of the lung among US White men for the period 1973–2000. These expected rates are compared to observed rates for the same birth cohorts of White men in the US Surveillance, Epidemiology and End Results (SEER) data. Results Changes in smoking behaviors over the past several decades adequately explain the changes in squamous cell carcinoma rates observed in the SEER data. However, predicted rates for adenocarcinoma do not match the observed SEER data without inclusion of a term increasing the risk for adenocarcinoma with the duration of smoking after 1965. Conclusion The risk of developing squamous cell carcinoma from smoking appears to have remained stable in the United States over the past several decades; however, the risk of adenocarcinoma has increased substantially in a pattern temporally associated with changes in cigarette design.
- Open Access
- 28 March 2008
- Published by BMJ in Tobacco Control
- Vol. 17 (2) , 132-141
Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal
- 28 March 2008
- Published by BMJ in Tobacco Control
- Vol. 17 (2) , 132-141
Open AccessMandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal
- 27 November 2006
- Published by BMJ in Tobacco Control
- Vol. 15 (6) , 436-441
The temporal relationship between advertising and sales of low-tar cigarettes
Objective and hypothesis:To determine whether a temporal relationship exists between the advertising and sales of low-tar cigarettes. It was hypothesised that increases in the advertising of low-tar cigarettes would precede increases in sales for these cigarettes.Methods:The themes of cigarette advertisements were reviewed and coded for 20 low-tar cigarette brands advertised in 13 widely read magazines in the US between 1960 and 1996. These 20 brands represented most of the low-tar cigarette advertisements and cigarette sales from 1967 to 1996. Cigarette sales data were obtained from the 1994 Maxwell report that summarises all cigarette sales from 1925 to 1990. If the advertisement referred to the low-tar attributes of the cigarette advertised, the advertisement was coded as having a low-tar theme and was included in the analysis.Results:Five different graphical presentations of the relationship between the advertising and sales of the 20 low-tar cigarette brands showed a temporal relationship between low-tar advertising and sales for these brands. This relationship was observed for brands that introduced a low-tar alternative into an existing brand family (eg, Marlboro Light) and for new exclusively low-tar brands (eg, Carlton). Despite large increases in the advertising for the exclusively low-tar brands, sales of these brands remained low relative to sales of the low-tar alternative brands.Conclusions:Increases in print advertising of 20 of the most popular low-tar cigarette brands were followed by increases in sales for these cigarettes. Despite increases in the advertising of exclusively low-tar brands in the mid-1970s and early 1980s, the sales of these brands never matched the sales of the low-tar alternative brands. This suggests that it may have been easier to get smokers to switch to low-tar brands within a brand family compared with entirely new low-tar brands. Over the past 30 years, the marketing of low-tar cigarettes as a healthier alternative to higher-tar cigarettes has resulted in these brands dominating the market, and may have kept concerned smokers from quitting.
- 27 November 2006
- Published by BMJ in Tobacco Control
- Vol. 15 (6) , 436-441
The temporal relationship between advertising and sales of low-tar cigarettes
Objective and hypothesis:To determine whether a temporal relationship exists between the advertising and sales of low-tar cigarettes. It was hypothesised that increases in the advertising of low-tar cigarettes would precede increases in sales for these cigarettes.Methods:The themes of cigarette advertisements were reviewed and coded for 20 low-tar cigarette brands advertised in 13 widely read magazines in the US between 1960 and 1996. These 20 brands represented most of the low-tar cigarette advertisements and cigarette sales from 1967 to 1996. Cigarette sales data were obtained from the 1994 Maxwell report that summarises all cigarette sales from 1925 to 1990. If the advertisement referred to the low-tar attributes of the cigarette advertised, the advertisement was coded as having a low-tar theme and was included in the analysis.Results:Five different graphical presentations of the relationship between the advertising and sales of the 20 low-tar cigarette brands showed a temporal relationship between low-tar advertising and sales for these brands. This relationship was observed for brands that introduced a low-tar alternative into an existing brand family (eg, Marlboro Light) and for new exclusively low-tar brands (eg, Carlton). Despite large increases in the advertising for the exclusively low-tar brands, sales of these brands remained low relative to sales of the low-tar alternative brands.Conclusions:Increases in print advertising of 20 of the most popular low-tar cigarette brands were followed by increases in sales for these cigarettes. Despite increases in the advertising of exclusively low-tar brands in the mid-1970s and early 1980s, the sales of these brands never matched the sales of the low-tar alternative brands. This suggests that it may have been easier to get smokers to switch to low-tar brands within a brand family compared with entirely new low-tar brands. Over the past 30 years, the marketing of low-tar cigarettes as a healthier alternative to higher-tar cigarettes has resulted in these brands dominating the market, and may have kept concerned smokers from quitting.
- 1 September 2005
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (9) , 2131-2136
The Effect of Over-the-Counter Sales of the Nicotine Patch and Nicotine Gum on Smoking Cessation in California
The Food and Drug Administration approved over-the-counter (OTC) sale of nicotine gum and nicotine patches in 1996. We used data from the 1996 California Tobacco Survey to compare the rates of nicotine replacement therapy (NRT) use and smoking abstinence in California for each month during a period immediately preceding and immediately following the OTC availability of nicotine gum and patches. For smokers eligible to report a quit attempt, the proportion making a quit attempt using NRT and the proportion remaining abstinent was calculated for each of the 12 months prior to the survey interview. Multiple regression modeling of quit attempts and abstinence included a term for the number of months between the quit attempt and survey interview and dummy variables for the months before and after the OTC availability of NRT. Results showed a significant increase in the fraction of smokers using the patch (P < 0.01) and gum (P < 0.05) immediately following their availability OTC. There was also a significantly higher proportion of smokers reporting abstinence with gum use (P < 0.01) and a significant increase in reported abstinence with patch use (P < 0.01) during the period of time immediately following the availability of these products without a prescription. The results of this study suggest that removing the prescription status of NRT products resulted in an immediate increase in quit attempts and smoking abstinence with the use of nicotine gum or patches.
- 1 September 2005
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (9) , 2131-2136
The Effect of Over-the-Counter Sales of the Nicotine Patch and Nicotine Gum on Smoking Cessation in California
The Food and Drug Administration approved over-the-counter (OTC) sale of nicotine gum and nicotine patches in 1996. We used data from the 1996 California Tobacco Survey to compare the rates of nicotine replacement therapy (NRT) use and smoking abstinence in California for each month during a period immediately preceding and immediately following the OTC availability of nicotine gum and patches. For smokers eligible to report a quit attempt, the proportion making a quit attempt using NRT and the proportion remaining abstinent was calculated for each of the 12 months prior to the survey interview. Multiple regression modeling of quit attempts and abstinence included a term for the number of months between the quit attempt and survey interview and dummy variables for the months before and after the OTC availability of NRT. Results showed a significant increase in the fraction of smokers using the patch (P < 0.01) and gum (P < 0.05) immediately following their availability OTC. There was also a significantly higher proportion of smokers reporting abstinence with gum use (P < 0.01) and a significant increase in reported abstinence with patch use (P < 0.01) during the period of time immediately following the availability of these products without a prescription. The results of this study suggest that removing the prescription status of NRT products resulted in an immediate increase in quit attempts and smoking abstinence with the use of nicotine gum or patches.
- 1 July 2003
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 46 (1) , 11-29
Epidemiology of smoking-induced cardiovascular disease
- 1 July 2003
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 46 (1) , 11-29
Epidemiology of smoking-induced cardiovascular disease
- 1 September 2002
- Published by Wiley in Journal of Dental Education
- Vol. 66 (9) , 1051-1060
Reducing Tobacco Use: What Works in the Population?
One‐half of those who have ever smoked cigarettes are currently former smokers. This cessation coincided with a forty‐year effort to educate and inform smokers about the risks of smoking. This paper examines the effects of several tobacco control interventions for smokers in the general population using population‐based survey data. States with large media‐led tobacco control programs have higher rates of smoking cessation, suggesting that these comprehensive approaches can alter smoking behavior. This paper also presents evidence supporting effects on smoking cessation for restrictions on where people can smoke, increases in the cost of cigarettes, provision of physician advice to quit coupled with cessation assistance, pharmacological assistance, and telephone hotlines. It also provides evidence that many of these interventions are being implemented in the general population in ways that are less effective than expected based on clinical trials. Increasing the effectiveness of these interventions and linking multiple interventions to provide synergy offer great opportunities to improve rates of population‐based cessation.
- 1 September 2002
- Published by Wiley in Journal of Dental Education
- Vol. 66 (9) , 1051-1060
Reducing Tobacco Use: What Works in the Population?
One‐half of those who have ever smoked cigarettes are currently former smokers. This cessation coincided with a forty‐year effort to educate and inform smokers about the risks of smoking. This paper examines the effects of several tobacco control interventions for smokers in the general population using population‐based survey data. States with large media‐led tobacco control programs have higher rates of smoking cessation, suggesting that these comprehensive approaches can alter smoking behavior. This paper also presents evidence supporting effects on smoking cessation for restrictions on where people can smoke, increases in the cost of cigarettes, provision of physician advice to quit coupled with cessation assistance, pharmacological assistance, and telephone hotlines. It also provides evidence that many of these interventions are being implemented in the general population in ways that are less effective than expected based on clinical trials. Increasing the effectiveness of these interventions and linking multiple interventions to provide synergy offer great opportunities to improve rates of population‐based cessation.